Yeshwant Krishna
Insider CIK 1585001 · FMI Director, 10% owner · PBLS Director · VERV Director, 10% owner · EQRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PBLS Parabilis Medicines, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 20,215 | — | $0 | 20,215 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 42,200 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | D To issuer deriv | 2025-07-25 | 2025-07-28 | 136,139 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | U Tender | 2025-07-25 | 2025-07-28 | 6,108,442 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | U Tender | 2025-07-25 | 2025-07-28 | 4,260,047 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | U Tender | 2025-07-25 | 2025-07-28 | 1,800,000 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 42,200 | — | $0 | 42,200 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 136,139 | — | $0 | 136,139 | SEC↗ |
| VERV Verve Therapeutics, Inc. | P Buy | 2023-12-01 | 2023-12-05 | 1,800,000 | $10.00 | $18.00M | 1,800,000 | SEC↗ |
| EQRX EQRx, Inc. | D To issuer deriv | 2023-11-09 | 2023-11-09 | 101,010 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 26,642 | — | $0 | 26,642 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-04 | 2022-11-08 | 47,690 | $31.12 | $1.48M | 4,260,940 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-04 | 2022-11-08 | 650 | $31.99 | $20.8K | 4,260,290 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-04 | 2022-11-08 | 243 | $32.90 | $8.0K | 4,260,047 | SEC↗ |
| VERV Verve Therapeutics, Inc. | J Other | 2022-11-04 | 2022-11-08 | 48,583 | — | $0 | 6,108,442 | SEC↗ |
| VERV Verve Therapeutics, Inc. | J Other | 2022-11-03 | 2022-11-04 | 49,569 | — | $0 | 6,157,025 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-03 | 2022-11-04 | 25,534 | $33.14 | $846.2K | 4,310,385 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-03 | 2022-11-04 | 1,755 | $33.84 | $59.4K | 4,308,630 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-03 | 2022-11-04 | 22,279 | $32.32 | $720.1K | 4,335,919 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-04 | 8,930 | $36.78 | $328.4K | 4,358,198 | SEC↗ |
| VERV Verve Therapeutics, Inc. | J Other | 2022-11-02 | 2022-11-04 | 28,651 | — | $0 | 6,206,594 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-04 | 10,372 | $36.28 | $376.3K | 4,367,128 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-04 | 9,350 | $34.78 | $325.2K | 4,377,500 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 29,326 | $36.69 | $1.08M | 4,389,487 | SEC↗ |
| VERV Verve Therapeutics, Inc. | J Other | 2022-11-01 | 2022-11-02 | 31,963 | — | $0 | 6,235,245 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 2,377 | $37.82 | $89.9K | 4,387,110 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 260 | $38.64 | $10.0K | 4,386,850 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 88 | $40.64 | $3.6K | 4,418,813 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 6,601 | $40.16 | $265.1K | 4,418,901 | SEC↗ |
| VERV Verve Therapeutics, Inc. | J Other | 2022-10-31 | 2022-11-02 | 53,697 | — | $0 | 6,267,208 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 23,732 | $37.91 | $899.7K | 4,448,777 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 23,275 | $38.94 | $906.3K | 4,425,502 | SEC↗ |
| EQRX EQRx, Inc. | A Award deriv | 2022-09-30 | 2022-10-04 | 101,010 | — | $0 | 101,010 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 15,500 | — | $0 | 15,500 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-22 | 37,308,792 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-22 | 4,104,416 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-22 | 58,528,428 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-22 | 443,265 | — | $0 | 4,472,509 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-22 | 4,029,244 | — | $0 | 4,029,244 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-22 | 6,320,905 | — | $0 | 6,320,905 | SEC↗ |
| FMI Foundation Medicine, Inc. | U Tender | 2018-07-31 | 2018-08-02 | 5,786 | $137.00 | $792.7K | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | S Sale | 2017-08-08 | 2017-08-10 | 4,800 | $40.01 | $192.0K | 5,786 | SEC↗ |
| FMI Foundation Medicine, Inc. | M Exercise deriv | 2017-08-04 | 2017-08-08 | 13,385 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | F Tax w/h | 2017-08-04 | 2017-08-08 | 8,585 | $37.75 | $324.1K | 10,586 | SEC↗ |
| FMI Foundation Medicine, Inc. | M Exercise | 2017-08-04 | 2017-08-08 | 13,385 | $24.21 | $324.1K | 19,171 | SEC↗ |
| FMI Foundation Medicine, Inc. | S Sale | 2017-08-04 | 2017-08-08 | 18,072 | $36.85 | $666.0K | 5,786 | SEC↗ |
| FMI Foundation Medicine, Inc. | A Award | 2017-06-20 | 2017-06-22 | 5,786 | $40.05 | $231.7K | 23,858 | SEC↗ |
| FMI Foundation Medicine, Inc. | A Award | 2016-06-16 | 2016-06-20 | 12,075 | $19.93 | $240.7K | 18,072 | SEC↗ |
| FMI Foundation Medicine, Inc. | A Award | 2015-06-18 | 2015-06-22 | 5,997 | $32.23 | $193.3K | 5,997 | SEC↗ |
| FMI Foundation Medicine, Inc. | S Sale | 2015-06-15 | 2015-06-15 | 114,481 | $32.33 | $3.70M | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | S Sale | 2015-06-12 | 2015-06-15 | 53,645 | $33.72 | $1.81M | 114,481 | SEC↗ |
| FMI Foundation Medicine, Inc. | S Sale | 2015-06-11 | 2015-06-15 | 15,734 | $35.14 | $552.9K | 168,126 | SEC↗ |
| FMI Foundation Medicine, Inc. | S Sale | 2015-05-14 | 2015-05-18 | 8,600 | $38.57 | $331.7K | 183,860 | SEC↗ |
| FMI Foundation Medicine, Inc. | U Tender | 2015-04-07 | 2015-04-09 | 923,735 | $50.00 | $46.19M | 220,917 | SEC↗ |
| FMI Foundation Medicine, Inc. | U Tender | 2015-04-07 | 2015-04-16 | 952,192 | $50.00 | $47.61M | 192,460 | SEC↗ |
| FMI Foundation Medicine, Inc. | A Award deriv | 2014-06-18 | 2014-06-20 | 13,385 | — | $0 | 13,385 | SEC↗ |
| FMI Foundation Medicine, Inc. | S Sale | 2014-06-13 | 2014-06-17 | 1,300,000 | $22.40 | $29.12M | 1,144,653 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion deriv | 2013-09-30 | 2013-10-02 | 6,742,537 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion deriv | 2013-09-30 | 2013-10-02 | 3,036,075 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion | 2013-09-30 | 2013-10-02 | 759,018 | — | $0 | 2,444,653 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion | 2013-09-30 | 2013-10-02 | 1,685,635 | — | $0 | 1,685,635 | SEC↗ |